A reproductive endocrinology clinic utilizes various pharmacotherapy regimens to treat patients with anovulatory and anatomical infertility. For each clinical scenario describing a patient receiving an infertility treatment, match the appropriate intervention with its primary pathophysiological mechanism of action.
- A 29-year-old with irregular menses, acne, and an ultrasound showing enlarged ovaries with peripheral cysts is prescribed the preferred first-line oral medication to induce ovulation.Inhibition of the aromatase enzyme, which lowers circulating estrogen levels and triggers increased endogenous gonadotropin release from the anterior pituitary.
- A 31-year-old undergoing controlled ovarian hyperstimulation for in vitro fertilization receives an injectable medication exactly 36 hours before scheduled transvaginal oocyte retrieval.Direct binding and stimulation of the luteinizing hormone (LH) receptor, structurally mimicking the mid-cycle endogenous LH surge to finalize oocyte maturation.
- A 33-year-old with amenorrhea, bilateral milky nipple discharge, and a pituitary microadenoma is prescribed an oral medication to restore normal ovulatory cycles.Agonism of central dopamine D2 receptors, which suppresses excessive lactotroph secretion and removes negative regulation on gonadotropin-releasing hormone (GnRH).
- A 34-year-old with unexplained infertility is prescribed an oral medication that historically serves as an alternative first-line agent, functioning by interacting with central receptors to induce multifollicular development.Competitive blockade of hypothalamic estrogen receptors, which prevents physiological negative feedback and stimulates gonadotropin secretion.
Cevap
The clinical scenarios correspond to the mechanisms of letrozole (aromatase inhibition), hCG (LH receptor stimulation), dopamine agonists (D2 receptor agonism), and clomiphene citrate (estrogen receptor blockade), respectively.
Successful fertility treatment requires targeting the specific pathophysiological defect. Letrozole targets aromatase to reduce estrogen synthesis in PCOS. hCG acts directly on ovarian LH receptors to mimic the LH surge. Dopamine agonists directly suppress prolactin hypersecretion by stimulating D2 receptors. Clomiphene competitively blocks estrogen receptors centrally.
Adım Adım Çözüm
Anahtar Kavram
Pharmacotherapy for ovulation induction requires targeting the specific pathophysiologic defect, utilizing mechanisms such as aromatase inhibition, estrogen receptor modulation, LH receptor agonism, or dopamine agonism.